Page last updated: 2024-08-23

zidovudine and Myelodysplastic Syndromes

zidovudine has been researched along with Myelodysplastic Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullis, JE; Cronkite, EP; Hirabayashi, Y; Inoue, T; Mitsui, H; Umemura, T1
Biesma, DH1

Reviews

1 review(s) available for zidovudine and Myelodysplastic Syndromes

ArticleYear
Erythropoietin treatment for non-uremic patients: a personal view.
    The Netherlands journal of medicine, 1999, Volume: 54, Issue:1

    Topics: Anemia; Anti-HIV Agents; Arthritis, Rheumatoid; Blood Transfusion, Autologous; Chemotherapy, Adjuvant; Erythropoietin; Female; Humans; Male; Multiple Myeloma; Myelodysplastic Syndromes; Recombinant Proteins; Uremia; Zidovudine

1999

Other Studies

1 other study(ies) available for zidovudine and Myelodysplastic Syndromes

ArticleYear
Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
    Leukemia, 1997, Volume: 11 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Anemia, Macrocytic; Animals; Anti-HIV Agents; Bone Marrow; Colony-Forming Units Assay; Erythrocyte Count; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hyperplasia; Male; Mice; Mice, Inbred CBA; Myelodysplastic Syndromes; Thrombocytopenia; Time Factors; Zidovudine

1997